EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems

Xuejia Kang iD, Sanika Jadhav iD, Manjusha Annaji, Chung-Hui Huang, Rajesh Amin, Jianzhong Shen, Charles R Ashby, Amit K Tiwari iD, R Jayachandra Babu iD, Pengyu Chen iD

Pharmaceutics · 23.05.2023 · 15 (6) · 1567

DOI: 10.3390/pharmaceutics15061567 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.05.2023. Verfasst von Xuejia Kang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disulfiram (DSF) is a thiocarbamate based drug that has been approved for treating alcoholism for over 60 years. Preclinical studies have shown that DSF has anticancer efficacy, and its supplementation with copper (CuII) significantly potentiates the efficacy of DSF. However, the results of clinical trials have not yielded promising results. The elucidation of the anticancer mechanisms of DSF/Cu (II) will be beneficial in repurposing DSF as a new treatment for certain types of cancer. DSF’s anticancer mechanism is primarily due to its generating reactive oxygen species, inhibiting aldehyde dehydrogenase (ALDH) activity inhibition, and decreasing the levels of transcriptional proteins. DSF also shows inhibitory effects in cancer cell proliferation, the self-renewal of cancer stem cells (CSCs), angiogenesis, drug resistance, and suppresses cancer cell metastasis. This review also discusses current drug delivery strategies for DSF alone diethyldithocarbamate (DDC), Cu (II) and DSF/Cu (II), and the efficacious component Diethyldithiocarbamate–copper complex (CuET).

Schlagwörter

Stichwörter der Autor:innen

cancercuproptosisdisulfiram/copperdrug delivery systemsimmunomodulatory effectsnanomedicines

Autor:innen und Institutionen

  • Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Materials Research and Education Center, Materials Engineering, Department of Mechanical Engineering, Auburn University, Auburn, AL 36849, USA.
  • Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, St. John's University, Queens, NY 11431, USA.
  • Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.

ORCID-Profile: Xuejia Kang, Sanika Jadhav, Amit K Tiwari, R Jayachandra Babu, Pengyu Chen

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health (NIH)

Zitieren

APA

Kang, X., Jadhav, S., Annaji, M., Huang, C. H., Amin, R., Shen, J., Ashby, C. R., Tiwari, A. K., Babu, R. J., & Chen, P. (2023). Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems. Pharmaceutics, 15(6), 1567. https://doi.org/10.3390/pharmaceutics15061567

Vancouver

Kang X, Jadhav S, Annaji M, Huang CH, Amin R, Shen J, et al. Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems. Pharmaceutics. 2023;15(6):1567. doi:10.3390/pharmaceutics15061567

BibTeX
@article{Kang2023,
  author = {Kang, Xuejia and Jadhav, Sanika and Annaji, Manjusha and Huang, Chung-Hui and Amin, Rajesh and Shen, Jianzhong and Ashby, Charles R and Tiwari, Amit K and Babu, R Jayachandra and Chen, Pengyu},
  title = {Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1567},
  doi = {10.3390/pharmaceutics15061567}
}
Kostenlos starten →